1 |
da Rosa-junior NT, Parmeggiani B, Glänzel NM, de Moura Alvorcem L, Brondani M, Britto R, Grings M, Ortiz VD, Turck P, da Rosa Araujo AS, Wajner M, Leipnitz G. Antioxidant system disturbances and mitochondrial dysfunction induced by 3-methyglutaric acid in rat heart are prevented by bezafibrate. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174950] [Reference Citation Analysis]
|
2 |
Pesce V, Lezza AMS. mtDNA and Mitochondrial Stress Signaling in Human Diseases: A Special Issue. Int J Mol Sci 2020;21:E2617. [PMID: 32283804 DOI: 10.3390/ijms21072617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
3 |
Pitceathly RDS, Keshavan N, Rahman J, Rahman S. Moving towards clinical trials for mitochondrial diseases. J Inherit Metab Dis 2021;44:22-41. [PMID: 32618366 DOI: 10.1002/jimd.12281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
4 |
Sacchetto C, Sequeira V, Bertero E, Dudek J, Maack C, Calore M. Metabolic Alterations in Inherited Cardiomyopathies. J Clin Med 2019;8:E2195. [PMID: 31842377 DOI: 10.3390/jcm8122195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
5 |
Almannai M, Salah A, El-Hattab AW. Mitochondrial Membranes and Mitochondrial Genome: Interactions and Clinical Syndromes. Membranes (Basel) 2022;12:625. [PMID: 35736332 DOI: 10.3390/membranes12060625] [Reference Citation Analysis]
|
6 |
Chin MT, Conway SJ. Role of Tafazzin in Mitochondrial Function, Development and Disease. J Dev Biol 2020;8:E10. [PMID: 32456129 DOI: 10.3390/jdb8020010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|